Folate deficiency causes megaloblastic macrocytosis with elevated MCV and MCH.

Folate deficiency is a well-established cause of megaloblastic anemia, a condition characterized by distinct morphological changes in red blood cells resulting from the disruption of essential metabolic pathways.

Mechanistic basis of DNA synthesis impairment

Folate deficiency fundamentally impairs DNA synthesis by disrupting one-carbon metabolism. Folate (as 5,10-methylene tetrahydrofolate) is a critical cofactor for the enzyme thymidylate synthase, which converts deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP).

• Thymidine depletion: When folate levels are insufficient, dTMP production drops, leading to a shortage of deoxythymidine triphosphate (dTTP) for DNA replication.
• DNA fragmentation: This shortage causes the misincorporation of uracil into DNA. The subsequent attempts by the cell to repair this through base excision repair result in repetitive, futile cycles of repair, leading to double-strand breaks and DNA fragmentation.
• Nuclear-cytoplasmic asynchrony: In the bone marrow, where cell turnover is high, this defect causes the nucleus to mature more slowly than the cytoplasm. While RNA and protein synthesis (including hemoglobin) continue relatively normally, DNA replication lags, creating enlarged, immature erythroid precursors called megaloblasts.

Clinical and hematological manifestations

The disruption of erythropoiesis in the bone marrow translates to specific markers in peripheral blood:

• Mean Corpuscular Volume (MCV): Folate deficiency consistently causes macrocytosis, with MCV typically exceeding 100 fL. In severe cases, MCV values often reach 110–120 fL.
• Mean Corpuscular Hemoglobin (MCH): MCH is elevated because the macrocytic cells are physically larger and contain a greater absolute amount of hemoglobin. However, the Mean Corpuscular Hemoglobin Concentration (MCHC) generally remains normal because hemoglobin production is not inherently defective.
• Ineffective erythropoiesis: The replication stress and DNA damage often lead to premature apoptosis of red cell precursors within the marrow, a process that contributes significantly to the severity of the resulting anemia.

Bottom line

The claim is fully supported by established science. Folate deficiency impairs DNA synthesis via thymidylate depletion, leading to nuclear-cytoplasmic asynchrony in the bone marrow and manifesting as megaloblastic macrocytosis with characteristically elevated MCV and MCH.